When many people begin researching medical weight loss, they immediately think of GLP-1 medications such as semaglutide, the active ingredient in Ozempic® and Wegovy®, or tirzepatide, the active ingredient in Mounjaro® and Zepbound®.
While these medications have helped many patients achieve their weight loss goals, they are not the only options available.
At Pro Health, medical weight loss is never based on a one-size-fits-all approach. Every patient has different health needs, lifestyle factors, and goals, which means the best treatment plan may look different from one person to the next.
That’s why your first consultation is focused on understanding you before recommending a treatment.
There Is No Single “Best” Weight Loss Medication
One of the biggest misconceptions about medical weight loss is that everyone should take the same medication.
The reality is much different.
Some patients may be excellent candidates for GLP-1 medications. Others may benefit from phentermine, fat-burning peptides, or another medically supervised option.
The goal isn’t to prescribe the newest medication. It’s to recommend the treatment that is most appropriate for your individual health and long-term success.
What Is Phentermine?
Phentermine is an FDA-approved prescription medication that has been used for many years to support weight loss in appropriate patients. It works as an appetite suppressant and is typically prescribed for short-term use as part of a comprehensive, medically supervised weight loss program.
Like any prescription medication, it is not right for everyone. During your consultation, your provider will review your health history, discuss your goals, and determine whether phentermine or another option may be appropriate.
Rather than making treatment decisions based on online trends, Pro Health develops recommendations based on the individual patient.
Medical Weight Loss Begins with a Comprehensive Evaluation
Every weight loss journey at Pro Health starts with a $75 consultation, which includes laboratory testing and a one-on-one evaluation with an experienced nurse practitioner.
During your appointment, you’ll discuss previous weight loss efforts, your current health, medications, lifestyle, and long-term goals.
From there, your provider will develop a personalized treatment plan designed around your specific needs.
See Also: Your Weight Loss Journey Doesn’t End with a Prescription
Your Treatment Plan Can Change Over Time
One advantage of medically supervised weight loss is flexibility.
As your body changes and your goals evolve, your treatment plan can evolve as well.
Some patients begin with one approach and later transition to another based on their progress. Others may benefit from combining medication with additional lifestyle recommendations or other wellness services.
Because patients return approximately every 30 days for follow-up appointments, there are regular opportunities to evaluate progress and make adjustments when appropriate.
Choosing the Right Weight Loss Partner
Successful weight loss is about much more than selecting a medication.
It’s about having experienced healthcare providers who understand your goals, monitor your progress, and help you navigate challenges along the way.
At Pro Health, patients receive personalized care, ongoing support, and access to multiple treatment options rather than a one-size-fits-all program.
Whether your provider recommends semaglutide, tirzepatide, phentermine, peptides, or another medically supervised approach, you’ll have a healthcare team committed to helping you achieve sustainable, long-term results.
With five convenient Memphis-area clinics, Pro Health provides personalized medical weight loss care, ongoing follow-up, and local support throughout every stage of your journey.
Important Disclosure
Semaglutide is the active ingredient in Ozempic® and Wegovy®. Tirzepatide is the active ingredient in Mounjaro® and Zepbound®.
Compounded semaglutide and compounded tirzepatide are compounded drug products that have not been approved by the U.S. Food and Drug Administration (FDA); have not been reviewed by the FDA for safety, effectiveness, or quality; and have not been demonstrated to the FDA to be safe or effective for their intended use. The manufacturing processes used to produce compounded medications have not been reviewed by the FDA. FDA-approved products containing semaglutide and tirzepatide are available. Ozempic® and Wegovy® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company.